Bharat Parenterals gets license and authorization for Favipiravir oral suspension for Covid treatment

Bharat Parenterals said that it has secured the license and authorization from Drugs Controller General of India (DCGI) and Central Drugs Standard Control Organisation (CDSCO) ... Read More